Eurofins Bioanalytical Services expands its technology footprint in Flow Cytometry with the addition of Novocyte Quanteon™. The flow cytometer provides an expanded set of capabilities that accommodate today’s high-end and increasingly sophisticated multi-color flow cytometry assays.
In this Bioanalysis Zone interview, David Lanham of Eurofins BioPharma Services discusses flow cytometry for pharmacodynamic biomarker analysis and receptor engagement in early clinical stage work. David also explains the challenges faced when using flow cytometry as an analytical tool, before sharing his thoughts on the progress that has been made to regulate and standardize the field.
Tags: Bioanalytical Testing, BioPharma, Leadership, Flow Cytometry, Biomarker Analysis, Receptor Engagement
Tags: Bioanalytical Testing, Cellular Response, Development, BioPharma, Immunology, Flow Cytometry
The immunogenecity of biologics is a significant concern, which can affect safety and efficacy. In this interview with Dr. Eric Bonner, we explore recent developments in immunogenecity, highlight key challenges when reviewing immunogenecity, and explore current regulations.
Tags: Immune Cell Function, Drug Development, Development, BioPharma, Technology, Immunogenecity, Immunology
Eurofins Bioanalytical Services expands its technology footprint with the addition of Quanterix® SR-X™. The Ultra-Sensitive Biomarker Detection, for the bench-top. Experience the unrivaled power of Simoa® single molecule digital detection technology now available in a compact size with increased workflow flexibility.
Tags: Bioanalytical Testing, BioPharma, Quanterix, Technology
Eurofins BioPharma Services is once again excited to sponsor and join over 1,000 professionals at the upcoming 13th WRIB conference in New Orleans from April 1-5, 2019.
Tags: Bioanalytical Testing, Development